IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 174 filers reported holding IMPAX LABORATORIES INC in Q2 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $42,704,000 | +2.2% | 2,195,476 | -12.6% | 0.00% | +33.3% |
| Q4 2017 | $41,801,000 | -14.6% | 2,510,662 | +4.1% | 0.00% | -25.0% |
| Q3 2017 | $48,973,000 | +15.4% | 2,412,834 | -8.5% | 0.00% | 0.0% |
| Q2 2017 | $42,451,000 | +20.2% | 2,636,521 | -5.6% | 0.00% | +33.3% |
| Q1 2017 | $35,319,000 | +14.1% | 2,791,842 | +19.5% | 0.00% | 0.0% |
| Q4 2016 | $30,947,000 | -36.7% | 2,335,651 | +13.2% | 0.00% | -40.0% |
| Q3 2016 | $48,920,000 | -3.3% | 2,064,118 | +17.6% | 0.01% | 0.0% |
| Q2 2016 | $50,595,000 | -9.2% | 1,755,609 | +0.8% | 0.01% | -16.7% |
| Q1 2016 | $55,742,000 | -29.4% | 1,740,986 | -5.8% | 0.01% | -33.3% |
| Q4 2015 | $78,997,000 | +15.4% | 1,847,596 | -5.0% | 0.01% | +12.5% |
| Q3 2015 | $68,454,000 | -30.7% | 1,944,253 | -9.6% | 0.01% | -27.3% |
| Q2 2015 | $98,774,000 | -8.3% | 2,151,068 | -6.4% | 0.01% | 0.0% |
| Q1 2015 | $107,736,000 | +38.8% | 2,298,653 | -6.2% | 0.01% | +37.5% |
| Q4 2014 | $77,612,000 | +20.3% | 2,449,967 | -10.0% | 0.01% | +14.3% |
| Q3 2014 | $64,536,000 | -8.4% | 2,722,222 | +15.9% | 0.01% | -12.5% |
| Q2 2014 | $70,422,000 | +27.4% | 2,348,197 | +12.2% | 0.01% | +33.3% |
| Q1 2014 | $55,284,000 | -32.9% | 2,092,319 | -41.8% | 0.01% | +20.0% |
| Q4 2013 | $82,390,000 | +95.0% | 3,593,012 | +74.4% | 0.01% | 0.0% |
| Q3 2013 | $42,255,000 | -7.3% | 2,060,275 | -9.8% | 0.01% | -16.7% |
| Q2 2013 | $45,562,000 | – | 2,283,591 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |